Correspondence | Published:

United Kingdom

Illness should not curtail PhD funding

Nature volume 539, page 495 (24 November 2016) | Download Citation

As PhD students who were diagnosed with cancer during our training, we have first-hand experience of the financial consequences of taking time out for treatment and recovery. Cutting a student's stipend because of serious illness is standard practice in the United Kingdom, compounding the combined stresses of delays to the research project and of the condition itself.

In 3–4 years, UK doctoral students are expected to master new techniques and to generate a solid body of results for research papers and a thesis. Their university and funding contracts reflect this 'apprentice' status and come with restricted rights.

Training grants from the UK research councils typically allow 13 weeks of paid sick leave; the studentship is suspended if an illness is expected to last longer (see www.rcuk.ac.uk/funding/grantstcs). Other funders may not cover sick leave at all, and most universities do not step in to help.

As a result, a student who is ill can be forced to continue working, to rely on contributions from friends and relatives, or to quit their PhD — all unacceptable 'punishments' in our view. We suggest that training-grant contracts should be more similar to academic staff contracts in providing at least six months of paid sick leave.

Author information

Affiliations

  1. University of Oxford, UK.

    • Edwin S. Dalmaijer
  2. University of Cambridge, UK.

    • E. A. Claudia Pama
  3. University College London, UK.

    • Stella Prins

Authors

  1. Search for Edwin S. Dalmaijer in:

  2. Search for E. A. Claudia Pama in:

  3. Search for Stella Prins in:

Corresponding author

Correspondence to Edwin S. Dalmaijer.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/539495e

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing